(Q39149101)

English

Effect of artesunate and mefloquine in combination on the Fridericia corrected QT intervals in Plasmodium falciparum infected adults from Thailand

scientific article published on 10 January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Effect of artesunate and mefloquine in combination on the Fridericia corrected QT intervals in Plasmodium falciparum infected adults from Thailand (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Plasmodium falciparum

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

Sornchai Looareesuwan

2

object named as

S Looareesuwan

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

author name string

S Krudsood

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

P Wilairatama

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

W Leowattana

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

N Tangpukdee

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

K Chalermrut

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

S Ramanathan

7

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

V Navaratnam

8

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

P Olliaro

9

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

M Vaillant

10

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

J R Kiechel

11

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

W R J Taylor

12

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

10 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Tropical Medicine and International Health

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

458-465

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02714.X

21 January 2018

Measurement and interpretation of QT dispersion.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02714.X

21 January 2018

Cardiac effects of co-artemether (artemether/lumefantrine) and mefloquine given alone or in combination to healthy volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02714.X

21 January 2018

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02714.X

21 January 2018

Atrial flutter with 1:1 conduction after administration of the antimalarial drug mefloquine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02714.X

21 January 2018

New Fixed-Dose Artesunate-Mefloquine Formulation against Multidrug-Resistant Plasmodium falciparum in Adults: a Comparative Phase IIb Safety and Pharmacokinetic Study with Standard-Dose Nonfixed Artesunate plus Mefloquine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02714.X

21 January 2018

The anti-malarial drug halofantrine and its metabolite N-desbutylhalofantrine block HERG potassium channels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02714.X

21 January 2018

Cardiac complications of halofantrine: a prospective study of 20 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02714.X

21 January 2018

Cardiac effects of antimalarial treatment with halofantrine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02714.X

21 January 2018

A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02714.X

21 January 2018

Lack of a significant adverse cardiovascular effect of combined quinine and mefloquine therapy for uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02714.X

21 January 2018

Use of weight-for-age-data to optimize tablet strength and dosing regimens for a new fixed-dose artesunate-amodiaquine combination for treating falciparum malaria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02714.X

21 January 2018

Cardiotoxicity of antimalarial drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02714.X

21 January 2018

Drug induced QT prolongation and torsades de pointes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02714.X

21 January 2018

Identifiers

10.1111/J.1365-3156.2010.02714.X

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39149101&oldid=1809632965"